Antibiotic-resistant Acinetobacter baumannii infections among patients in hospital settings are rising at an alarming rate. The World Health Organization has designated carbapenem-resistant A. baumannii as a priority pathogen for drug discovery. Based on the open drug discovery approach, we screened 400 compounds provided as a Pandemic Response Box by MMV and DNDi to identify compounds with antibacterial and antibiofilm activity against two A. baumannii reference strains using a highly robust resazurin assay. In vitro screening identified thirty compounds with MIC ≤ 50μM having growth inhibitory properties against the planktonic state. Five compounds, with MMV IDs MMV396785, MMV1578568, MMV1578574, MMV1578564, and MMV1579850, were able to reduce metabolically active cells in the biofilm state. Of these five compounds, MMV396785 showed potential antibacterial and antibiofilm activity with MIC, MBIC, and MBEC of 3.125 μM, 12.5, and 25–100 µM against tested A. baumannii strains, respectively, showing biofilm formation inhibition by 93% and eradication of pre-formed biofilms by 60–77.4%. In addition, MMV396785 showed a drastic reduction in the surface area and thickness of biofilms. Further investigations at the molecular level by qRT-PCR revealed the downregulation of biofilm-associated genes when exposed to 50 µM MMV396785 in all tested strains. This study identified the novel compound MMV396785 as showing potential in vitro antibacterial and antibiofilm efficacy against A. baumannii.

More from our Archive

• DOI: 10.3390/vaccines11071217 2023

  Artificial Intelligence and Public Health: Evaluating ChatGPT Responses to Vaccination Myths and Misconceptions

  Giovanna Deiana, Marco Dettori, Antonella Arghittu, Antonio Azara, Giovanni Gabutti, Paolo Castiglia

• DOI: 10.1111/apt.17622 2023

  Review article: Translating STRIDE‐II into clinical reality – Opportunities and challenges

  Axel Dignass, Stefan Rath, Thomas Kleindienst, Andreas Stallmach

• DOI: 10.1111/cns.14341 2023

  Evaluation of <scp>α‐synuclein</scp> in <scp>CNS</scp>‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis

  Hash Brown Taha, Shomik S. Ati

• DOI: 10.3390/jnt4030012 2023

  Emerging Trends in the Application of Green Synthesized Biocompatible ZnO Nanoparticles for Translational Paradigm in Cancer Therapy

  Shaikh Sheeran Naser, Basab Ghosh, Faizan Zarreen Simnani, Dibyangshee Singh, Anmol Choudhury, Aditya Nandi, Adrija Sinha, Ealisha Jha, Pritam Kumar Panda, Mrutyunjay Suar, Suresh K. Verma

• DOI: 10.1111/apt.17637 2023

  Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes

  Selena Z. Kuo, Sandra Cepin, Jaclyn Bergstrom, Harris Siddiqi, Jinho Jung, Scarlett Lopez, Daniel Q. Huang, Pam Taub, Maral Amangurbanova, Rohit Loomba

• DOI: 10.1111/cns.14333 2023

  Ultrasound reduces inflammation by modulating <scp>M1</scp>/<scp>M2</scp> polarization of microglia through <scp>STAT1</scp>/<scp>STAT6</scp>/<scp>PPARγ</scp> signaling pathways

  Chin‐Hung Hsu, Yi‐Ju Pan, Yin‐Ting Zheng, Raymond Y. Lo, Feng‐Yi Yang

• DOI: 10.1111/apt.17631 2023

  Effects of social determinants of health on mortality and incident liver‐related events and cardiovascular disease in steatotic liver disease

  Vincent L. Chen, Michael W. Song, Deepika Suresh, Sharad I. Wadhwani, Ponni Perumalswami

• DOI: 10.3390/vaccines11071181 2023

  The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

  Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov, Tsvetelina Velikova

• DOI: 10.3390/vaccines11071177 2023

  COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India

  Nandini Sharma, Saurav Basu, Heena Lalwani, Shivani Rao, Mansi Malik, Sandeep Garg, Rahul Shrivastava, Mongjam Meghachandra Singh

• DOI: 10.1093/jac/dkad208 2023

  Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital <i>Mycoplasma genitalium</i> infections: a prospective cohort study

  Naokatsu Ando, Daisuke Mizushima, Misao Takano, Morika Mitobe, Kai Kobayashi, Hiroaki Kubota, Hirofumi Miyake, Jun Suzuki, Kenji Sadamasu, Takahiro Aoki, Koji Watanabe, Haruka Uemura, Yasuaki Yanagawa, Hiroyuki Gatanaga, Shinichi Oka